Dr Kevin Norris
Teams and roles for Kevin Norris
Research Associate
Honorary Research Fellow
Publication
2025
- Myers, K. C. et al., 2025. Clinical use of ZSCAN4 for telomere elongation in hematopoietic stem cells. NEJM Evidence 4 (3)(10.1056/EVIDoa2400252)
- Pazhakh, V. et al., 2025. A novel TERT variant associated with a telomere biology disorder and challenges in variant classification. eJHaem 6 (1) e1066. (10.1002/jha2.1066)
2024
- Louise, C. et al., 2024. Letter to the Editor: Telomere length and DNA methylation epitype both provide independent prognostic information in CLL patients; data from the UK CLL, ARCTIC and ADMIRE clinical trials. British Journal of Haematology 205 (5), pp.2072-2076. (10.1111/bjh.19765)
2023
- Hulme, C. H. et al., 2023. The upscale manufacture of chondrocytes for allogeneic cartilage therapies. Tissue Engineering Part C Methods 29 (9), pp.424-437. (10.1089/ten.TEC.2023.0037)
2022
- Pepper, A. G. S. et al., 2022. Combined analysis of IGHV mutations, telomere length and CD49d identifies long-term progression-free survivors in TP53 wild-type CLL treated with FCR-based therapies. Leukemia 36 , pp.271-274. (10.1038/s41375-021-01322-1)
2021
- Ashworth, I. et al. 2021. Telomere length in Cystic Fibrosis patients - are patients with CF ageing too quickly?. International Journal of Aging Research 4 90. (10.28933/ijoar-2021-06-2005)
- Norris, K. et al. 2021. High-throughput STELA provides a rapid test for the diagnosis of telomere biology disorders. Human Genetics 140 , pp.945-955. (10.1007/s00439-021-02257-4)
2020
- Pepper, C. , Norris, K. and Fegan, C. 2020. Clinical utility of telomere length measurements in cancer. Current Opinion in Genetics and Development 60 , pp.107-111. (10.1016/j.gde.2020.02.012)
2019
- Norris, K. et al. 2019. Telomere length predicts for outcome to FCR chemotherapy in CLL. Leukemia 33 , pp.1953-1963. (10.1038/s41375-019-0389-9)
2018
- Cleal, K. , Norris, K. and Baird, D. 2018. Telomere length dynamics and the evolution of cancer genome architecture. International Journal of Molecular Sciences 19 (2), pp.482-482. (10.3390/ijms19020482)
- Pilsworth, J. A. et al., 2018. TERT promoter mutation in adult granulosa cell tumor of the ovary. Modern Pathology 31 , pp.1107-1115. (10.1038/s41379-018-0007-9)
2014
- Lin, T. T. et al., 2014. Telomere dysfunction accurately predicts clinical outcome in chronic lymphocytic leukaemia, even in patients with early stage disease. British Journal of Haematology 167 (2), pp.214-223. (10.1111/bjh.13023)
2013
- Norris, K. 2013. An investigation into the chromatin structure of human telomeres. PhD Thesis , Cardiff University.
Articles
- Ashworth, I. et al. 2021. Telomere length in Cystic Fibrosis patients - are patients with CF ageing too quickly?. International Journal of Aging Research 4 90. (10.28933/ijoar-2021-06-2005)
- Cleal, K. , Norris, K. and Baird, D. 2018. Telomere length dynamics and the evolution of cancer genome architecture. International Journal of Molecular Sciences 19 (2), pp.482-482. (10.3390/ijms19020482)
- Hulme, C. H. et al., 2023. The upscale manufacture of chondrocytes for allogeneic cartilage therapies. Tissue Engineering Part C Methods 29 (9), pp.424-437. (10.1089/ten.TEC.2023.0037)
- Lin, T. T. et al., 2014. Telomere dysfunction accurately predicts clinical outcome in chronic lymphocytic leukaemia, even in patients with early stage disease. British Journal of Haematology 167 (2), pp.214-223. (10.1111/bjh.13023)
- Louise, C. et al., 2024. Letter to the Editor: Telomere length and DNA methylation epitype both provide independent prognostic information in CLL patients; data from the UK CLL, ARCTIC and ADMIRE clinical trials. British Journal of Haematology 205 (5), pp.2072-2076. (10.1111/bjh.19765)
- Myers, K. C. et al., 2025. Clinical use of ZSCAN4 for telomere elongation in hematopoietic stem cells. NEJM Evidence 4 (3)(10.1056/EVIDoa2400252)
- Norris, K. et al. 2019. Telomere length predicts for outcome to FCR chemotherapy in CLL. Leukemia 33 , pp.1953-1963. (10.1038/s41375-019-0389-9)
- Norris, K. et al. 2021. High-throughput STELA provides a rapid test for the diagnosis of telomere biology disorders. Human Genetics 140 , pp.945-955. (10.1007/s00439-021-02257-4)
- Pazhakh, V. et al., 2025. A novel TERT variant associated with a telomere biology disorder and challenges in variant classification. eJHaem 6 (1) e1066. (10.1002/jha2.1066)
- Pepper, A. G. S. et al., 2022. Combined analysis of IGHV mutations, telomere length and CD49d identifies long-term progression-free survivors in TP53 wild-type CLL treated with FCR-based therapies. Leukemia 36 , pp.271-274. (10.1038/s41375-021-01322-1)
- Pepper, C. , Norris, K. and Fegan, C. 2020. Clinical utility of telomere length measurements in cancer. Current Opinion in Genetics and Development 60 , pp.107-111. (10.1016/j.gde.2020.02.012)
- Pilsworth, J. A. et al., 2018. TERT promoter mutation in adult granulosa cell tumor of the ovary. Modern Pathology 31 , pp.1107-1115. (10.1038/s41379-018-0007-9)
Thesis
- Norris, K. 2013. An investigation into the chromatin structure of human telomeres. PhD Thesis , Cardiff University.